Stock listing
Grape King Bio Ltd.
Selected listing: 1707 · TWSE · TWD · TW
Grape King Bio Ltd. (TWSE:1707), Health Technology. Latest release Aug 10, 2022: Grape King Bio : Announcement of the Company obtains right-of-use assets…
- Ticker
- TWSE:1707
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- TWSE
- Currency
- TWD
About Grape King Bio Ltd.
Grape King Bio Ltd. is a public company listed on the Taiwan stock market under the ticker 1707. Grape King Bio specializes in the production of health supplements and functional foods, focusing on innovation and quality in its offerings.
Latest news from Grape King Bio Ltd.
Grape King Bio : Announcement of the Company obtains right-of-use assets from related parties
August 10, 2022
Grape King Bio : Announcement of the Company's Consolidated Financial Report for the second quarter of 2022 has been approved by the Board of Directors
August 10, 2022
Grape King Bio : Announcement of the record date decided for distribution of ex-dividend by the chairman.
May 27, 2022
Grape King Bio : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
May 27, 2022
Grape King Bio : Announcement for the Year 2022 ex-dividend record date on behalf of GRAPE KING BIO's major subsidiary, Pro-Partner Ltd.
April 19, 2022